Barclays lowered the firm’s price target on Cigna (CI) to $300 from $383 and keeps an Overweight rating on the shares. The firm updated the company’s model following the earnings report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna’s Strategic Initiatives Poised for Long-Term Growth Despite Short-Term Challenges
- Cigna Group Reports Strong Q3 2025 Results
- Midday Fly By: Big Tech reports, Novo tops Pfizer bid for Metsera
- Cigna says not providing guidance for 2026 EPS
- Morning Movers: Alphabet, Eli Lilly rise following quarterly results